Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001388325-26-000053

Stakes reported in this filing

Reporting person Shares Of the class
Novo Holdings A/S 3,000,000 5.4%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…